Pfizer's Bold Leap: Eyeing Metsara in Blockbuster Acquisition Bid

Oscar Health: The Next Healthcare Moonshot Poised for Explosive Growth, Threatening a Short Squeeze

The Weight of Success: Why Breakthrough Obesity Drugs Are a Budget Breaker

Global Health Titans Act: FDA Tightens Grip on Safe Weight-Loss Meds as WHO Elevates Them to Essential Status

Wegovy Triumphs: Novo Nordisk's Obesity Drug Significantly Cuts Heart Attack and Stroke Risk, Setting a New Benchmark in Cardiovascular Protection

Prothena's PRX012 Alzheimer's Drug Shines with 'Non-Competitive' Brain Swelling Rates, Offering New Hope

UK Healthcare on Edge: Mounjaro Shortages Loom as Eli Lilly's Price Hike Sparks Patient Panic

The Weighty Truth: Are Next-Gen Obesity Drugs Worth Their Premium Price Tag?

Healthcare Titans: UnitedHealth vs. Novo Nordisk – Which Giant Dominates Your Portfolio?